Global Surgical Site Infection Control Market size was valued at USD 5,255 Million in 2024 and is expected to reach USD 9,176.6 Million by 2033, at a CAGR of 5.67% during the forecast period 2024 – 2033.
Surgical Site Infection Control Market: Overview
Surgical Site Infection Control includes the prevention and mitigation of infections at surgical sites. It involves various measures, such as the use of antibiotics and infection prevention treatments.
Various factors, such as the rapidly expanding healthcare industry worldwide, growing surgical procedures in emerging economies, increasing prevalence of chronic diseases, increasing number of cosmetic surgeries worldwide, increasing usage of surgical infection technologies, and growing incidences of hospital-acquired infections, are some of the factors propelling the market growth of this region during the forecast period.
However, the high implementation cost of surgical site infection control measures, the dearth of skilled labour to carry out surgical infections, the lack of universal directives pertaining to surgical site infections, and the lack of adaptation in many underdeveloped countries are some of the factors restraining the market growth.
Growing collaborations between key players and end users to provide customized infection control products and technological innovations in surgical site infection control, such as the usage of advanced technologies, increasing spending on healthcare facilities, and growing supportive government policies, are expected to create lucrative opportunities for the market during the forecast period.
Key trends observed in the market include a growing emphasis on strengthening healthcare facilities and growing mergers and acquisitions, joint ventures, and collaborations among key players and other stakeholders. Thus, evolving trends are expected to create lucrative opportunities for the market during the forecast period.
The global Surgical Site Infection Control market is segmented by product, surgery, infection type, end user and region. By Product, the market is segmented into surgical scrubs, hair clippers, surgical drapes and surgical irrigation. Among all these, the surgical scrubs segment dominated the global surgical site infection control market and is expected to dominate during the forecast period due to the growing adoption of surgical scrubs across various end users such as hospitals, surgical centers and clinics.
By region, North America dominated the global surgical site infection control market and is expected to maintain its dominance during the forecast period owing to growing investment in healthcare facilities and the presence of many technology giants across the region.
Key countries, the U.S., Canada, and Mexico, are expected to drive the market growth of this region during the forecast period. Various factors, such as the growing geriatric population, increasing number of surgeries, increasing prevalence of chronic diseases, and growing supportive regulatory framework, are expected to create lucrative opportunities for market growth during the forecast period.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 5,255.7 Million |
| Projected Market Size in 2033 | USD 9,176.6 Million |
| Market Size in 2023 | USD 5,080 Million |
| CAGR Growth Rate | 5.67% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Product, Surgery/Procedure, Type of Infection, End-use and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your research requirements. |
CMI has comprehensively analyzed the Surgical Site Infection Control market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth market scenario. Segment-wise market size and market share during the forecast period have been duly addressed to portray the probable picture of this Global Surgical Site Infection Control industry.
The competitive landscape includes key innovators, after-market service providers, market giants, and niche players, who are studied and analyzed extensively with respect to their strengths, weaknesses, and value-adding prospects. In addition, this report covers key players’ profiles, market shares, mergers and acquisitions, consequent market fragmentation, and new trends and dynamics in partnerships.
List of the prominent players in the Surgical Site Infection Control Market:
- 3M
- AMERICAN POLYFILM INC.
- ANSELL LTD.
- Dickinson and Company)
- Becton
- Belimed AG
- BIOMÉRIEUX
- Covalon Technologies Ltd.
- Dickinson and Company
- Getinge Group
- Johnson & Johnson
- Kimberly-Clark Corporation
- Lac-Mac Limited
- Medtronic
- Mölnlycke AB
- Pacon Manufacturing
- PAUL HARTMANN AG
- Prescient Surgical
- Sotera Health
- bioMerieux SA
- Steris Corporation
- Stryker
- Others
The Surgical Site Infection Control Market is segmented as follows:
By Product
- Surgical scrubs
- Hair clippers
- Surgical drapes
- Surgical irrigation
By Surgery/Procedure
- Cataract surgery
- Cesarean section
- Dental restoration
- Gastric bypass
- Others
By Type of Infection
- Superficial incisional SSI
- Deep incisional SSI
- Organ or space SSI
By End-use
- Hospitals
- Ambulatory surgical centers
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America